Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P02452: Variant p.Gly767Ser

Collagen alpha-1(I) chain
Gene: COL1A1
Feedback?
Variant information Variant position: help 767 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Glycine (G) to Serine (S) at position 767 (G767S, p.Gly767Ser). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from glycine (G) to small size and polar (S) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In OI3; severe. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 767 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 1464 The length of the canonical sequence.
Location on the sequence: help DAGPKGADGSPGKDGVRGLT G PIGPPGPAGAPGDKGESGPS The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         DAGPKGADGSPGKDGVRGLTGPIGPPGPAGAPGDKGESGPS

                              DAGPKGADGSPGKDGVRGLTGPIGPPGPAGAPGDKGEAGPS

Mouse                         DAGPKGADGSPGKDGARGLTGPIGPPGPAGAPGDKGEAGPS

Rat                           DAGPKGADGSPGKDGVRGLTGPIGPPGPAGAPGDKGETGPS

Bovine                        DAGPKGADGAPGKDGVRGLTGPIGPPGPAGAPGDKGEAGPS

Chicken                       DPGPKGADGAPGKDGLRGLTGPIGPPGPAGAPGDKGEAGPP
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 162 – 1218 Collagen alpha-1(I) chain
Region 98 – 1214 Disordered
Region 179 – 1192 Triple-helical region
Modified residue 751 – 751 5-hydroxylysine
Modified residue 757 – 757 4-hydroxyproline
Modified residue 772 – 772 4-hydroxyproline
Modified residue 778 – 778 4-hydroxyproline
Modified residue 787 – 787 Phosphoserine



Literature citations
Severe (type III) osteogenesis imperfecta due to glycine substitutions in the central domain of the collagen triple helix.
Forlino A.; Zolezzi F.; Valli M.; Pignatti P.F.; Cetta G.; Brunelli P.C.; Mottes M.;
Hum. Mol. Genet. 3:2201-2206(1994)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 746-781; VARIANT OI3 SER-767; Mutational spectrum of type I collagen genes in Korean patients with osteogenesis imperfecta.
Lee K.S.; Song H.R.; Cho T.J.; Kim H.J.; Lee T.M.; Jin H.S.; Park H.Y.; Kang S.; Jung S.C.; Koo S.K.;
Hum. Mutat. 27:599-599(2006)
Cited for: VARIANTS OI1/OI3/OI4 ARG-194; ASP-242; ARG-257; SER-722; SER-767; SER-821 AND SER-1058;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.